Publications

Recent publications

Doctor

November 21, 2011

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).

Leuk Lymphoma. 2011 Mar;52(3):409-16. Epub 2011 Jan 28.

Tomás JF, Montalbán C, De Sevilla AF, Martínez-López J, Díaz N, Canales M, Martínez R, Sánchez-Godoy P, Caballero MD, Pe

November 15, 2011

Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.

Leuk Res. 2011 Apr;35(4):431-7. Epub 2010 Oct 27.

Rivero A, Rapado I, Tomás JF, Montalbán C, de Oña R, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, de Sevilla AF, de la Serna J, Mart

November 15, 2011

The challenge of recurrent follicular lymphoma.

Lancet Oncol. 2011 Aug;12(8):714-6. Epub 2011 Jul 1.

Tomás JF.

Follicular lymphoma is the second most common type of lymphoma in high-income countries, representing nearly 20% of all non-Hodgkin lymphomas. The